We report herein a highly efficient Cucatalyzed protocol for the conversion of aliphatic carboxylic acids to the corresponding difluoromethylated analogues. This robust, operationally simple and scalable protocol tolerates a variety of functional groups and can convert a diverse array of acid-containing complex molecules to the alkyl-CF 2 H products. Mechanistic studies support the involvement of alkyl radicals.
We report herein the first catalytic strategy to harness
amidyl
radicals derived from N-chloroamides for C–C
bond formation, allowing for the discovery of the first catalytic
benzylic C–H difluoromethylation. Under copper-catalyzed conditions,
a wide variety of N-chlorocarboxamides and N-chlorocarbamates direct selective benzylic C–H
difluoromethylation with a nucleophilic difluoromethyl source at room
temperature. This scalable protocol exhibits a broad substrate scope
and functional group tolerance, enabling late-stage difluoromethylation
of bioactive molecules. This copper-catalyzed, chloroamide-directed
strategy has also been extended to benzylic C–H pentafluoroethylation
and trifluoromethylation. Mechanistic studies on the difluoromethylation
reactions support that the reactions involve the formation of benzylic
radicals via intramolecular C–H activation, followed by the
copper-mediated transfer of difluoromethyl groups to the benzylic
radicals.
We
have developed an efficient synthesis of both (Z)-
and (E)-chlorohaloalkenes via hydrochlorination
of haloalkynes, based on two distinct hydrogen-bond-network-assisted
catalytic systems: Brønsted acid catalysis and gold catalysis.
Both systems offer high stereoselectivity, good chemical yields, and
diverse functional group tolerance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.